Sponsor: 
Seqirus
Administration route: 
Intramuscular injection, Subcutaneous injection
Vaccine group: 
Adults aged ≥65 years only

Registered for use in people aged ≥65 years.

Adjuvanted trivalent inactivated influenza vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 15 µg haemagglutinin of each of the 3 recommended influenza virus strains.

These are adjuvanted with MF59C.1. The adjuvant includes:

  • 9.75 mg squalene
  • 1.175 mg polysorbate 80

May contain traces of:

  • kanamycin
  • neomycin
  • formaldehyde
  • barium sulfate
  • cetyltrimethylammonium bromide
  • ovalbumin
  • latex

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
23 April 2019
Last reviewed: 
23 April 2019